Remedent, Inc. (REMI)
OTCMKTS
· Delayed Price · Currency is USD
0.0100
0.00 (0.00%)
At close: Jun 30, 2025
Remedent Employees
Remedent had 3 employees as of March 31, 2023. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$16,700
Profits / Employee
-$110,145
Market Cap
192.73K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
American Oncology Network | 1,914 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 116 |
Remedent News
- 4 years ago - Remedent, Inc. Files Form 15 to Suspend SEC Exchange Act Registration and Applies to Qualify for OTC Markets Alternative Reporting Standard for Pink Sheet Companies - GlobeNewsWire